| A gonadotropin-releasing hormone analogue impairs glucose tolerance in a diabetic patient. | |
| | |
MedLine Citation:
|
PMID: 9481560 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Changes in serum glucose levels were examined in a female with insulin-independent diabetes who received a gonadotropin-releasing hormone (GnRH) analog treatment for pelvic endometriosis. The mean blood glucose levels were higher on busereline therapy, and higher levels of hemoglobin A1c were noted on busereline therapy (range 6.9-12.5%) versus pre- and post-treatment (range 5.1-5.9%). Hormonal alteration induced by GnRH analog treatment may impair glucose tolerance. |
| | |
Authors:
|
A Imai; A Takagi; S Horibe; T Fuseya; H Takagi; T Tamaya |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: European journal of obstetrics, gynecology, and reproductive biology Volume: 76 ISSN: 0301-2115 ISO Abbreviation: Eur. J. Obstet. Gynecol. Reprod. Biol. Publication Date: 1998 Jan |
Date Detail:
|
Created Date: 1998-04-01 Completed Date: 1998-04-01 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 0375672 Medline TA: Eur J Obstet Gynecol Reprod Biol Country: IRELAND |
Other Details:
|
Languages: eng Pagination: 121-2 Citation Subset: IM |
Affiliation:
|
Department of Obstetrics and Gynecology, Gifu University School of Medicine, Japan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Blood Glucose / metabolism* Buserelin / adverse effects*, therapeutic use Danazol / therapeutic use Diabetes Mellitus, Type 1 / blood, complications* Endometriosis / complications, drug therapy* Estrogen Antagonists / therapeutic use Female Hemoglobin A, Glycosylated / metabolism Humans |
| Chemical | |
Reg. No./Substance:
|
0/Blood Glucose; 0/Estrogen Antagonists; 0/Hemoglobin A, Glycosylated; 17230-88-5/Danazol; 57982-77-1/Buserelin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Expression of matrix proteins in uterine cervical neoplasia using immunohistochemistry.
Next Document: Management and outcome of triplet pregnancy.